Eli Lilly & Co. (LLY) Tops Q4 EPS by 18c; offers guidance
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,102.08 --0%
EPS Growth %: +39.6%
Financial Fact:
Acquired in-process research and development: 0
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: +39.6%
Financial Fact:
Acquired in-process research and development: 0
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q4 EPS of $2.49, $0.18 better than the analyst estimate of $2.31. Revenue for the quarter came in at $9.35 billion versus the consensus estimate of $8.95 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2024 EPS of $12.20-$12.70, versus the consensus of $12.38. Eli Lilly & Co. sees FY2024 revenue of $40.4-41.6 billion, versus the consensus of $39.138 billion.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- Lilly declares third-quarter 2026 dividend
- Winnebago Industries (WGO) PT Lowered to $40 at Benchmark on Pressured NT Demand
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
